Stock·NYSE·Consumer Cyclical
Hilton Worldwide Holdings Inc. (HLT)
- Market cap
- $82.43B
- P/E
- 49.99
- Dividend yield
- 0.16%
- Street target
- $374.00median of 29 analysts
- 52-week range
- $263.95 $381.34
HLT stock forecast today
Where HLT stands today, and what CleaRank Financial AI makes of it.
HLT at a glance
Hilton Worldwide Holdings Inc. (HLT): Buy, 69/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($329.03 and $322.66).
- Earnings HLT beat estimates in 8 of its last 8 quarters, yet fell in the first session after 4 of those beats.
- Insiders Insiders sold $41.9M and made no open-market purchases over the last 18 months.
- Valuation P/E of 50.0 against 20.8 for the Consumer Cyclical sector: a premium to peers (+140%).
Figures as of November 6, 2026.
CleaRank Financial AI
HLT, or Hilton Worldwide Holdings Inc., carries a CleaRank rating of Buy and a model score of 69/100.
The trend is the biggest contributor: the price sits 14.81% above its 200-day average and 12.59% above its 50-day average, while the 50-day is 1.97% above the 200-day. Valuation is the biggest drag. The 50-day average is $329.03 and the 200-day is $322.66. Across the past year the price gained 39.65%.
Only on CleaRank
Figures we compute ourselves from HLT's own price, earnings and insider-filing history. Tap one to see it in context.
HLT stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $370.45 is 12.6% above the 50-day simple moving average of $329.03.Price above its 200-day average ›
The price is 14.8% above the 200-day simple moving average of $322.66.50-day average above the 200-day ›
The 50-day average ($329.03) is 2.0% above the 200-day average ($322.66), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 91% of its 52-week range, between $263.95 and $381.34.
HLT share price
Pick a period: each tab shows how far HLT has moved over it, to the last close.
Today's trading
Where HLT sits inside today's range and its 52-week range.
HLT fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/5P/E above the sector median ›
The trailing P/E of 49.99 is 140.3% above the Consumer Cyclical median of 20.8.P/S above the sector median ›
The price-to-sales ratio of 6.60 is 247.5% above the sector median of 1.9.Profitable over the last 12 months ›
Net income over the last 12 months was $1.6B on revenue of $12.5B, a net margin of 12.7%.Beat estimates in most recent reports ›
HLT beat the EPS estimate in 8 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 0.16%, or $0.6 a share a year.
Key statistics
The headline figures for HLT.
As of November 6, 2026, HLT trades at $370.45, with a market value of $82.43B, a P/E ratio of 49.99 and a dividend yield of 0.16%.
What the numbers say
CleaRank Financial AI's reading of HLT's valuation, growth and risks.
HLT's P/E of 49.99 is 140.3% above the 20.8 median for Consumer Cyclical stocks, so the P/E is at a premium to peers. Its market capitalisation stands at $82.4B, and trailing earnings are $7.41 a share.
The business converts sales into profit at a net margin of 12.7% and an operating margin of 66.79%. The balance sheet and payout round out the picture, with a trailing dividend yield of 0.16% ($0.60 a share a year).
EPS of $2.45 against an estimate of $2.37 made the October 27, 2026 report a beat of 3.38%. The market reacted the other way, with the stock falling 2.06% in the first session after the report.
HLT has beaten the EPS estimate in all 8 of its recent reports; even so, 4 of those 8 beats were followed by a lower share price in the first session after the report. Analysts' average EPS estimate for this fiscal year is $9.14, which would be growth of 12.7%, and $10.46 for next year (growth of 14.5%).
At a P/E of 49.99, which is 140.3% above the sector median, HLT is at a premium to peers, and that leaves little room for weaker results. The 30-day standard deviation of daily returns is 1.68%, and the beta against the S&P 500 is 1.07. Over the last 18 months insiders sold $41.9M of stock and bought none on the open market. Those sales are often planned in advance, so they carry less weight than purchases would.
HLT against the Consumer Cyclical sector
How HLT compares with the median Consumer Cyclical stock CleaRank tracks.
Price to earnings vs sector: HLT trades at a significant premium to sector peers (+140% against the sector median P/E). Investors are paying more for each dollar of earnings than for the typical stock in the sector.
Return vs SPY: Since May 28, 2025, HLT has gained 47.7% against a gain of 25.1% for SPY.
Performance against SPY
HLT and the S&P 500 (SPY) over the same days.
Revenue and earnings
How much HLT sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to June 30, 2026); HLT reported again on October 27, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue grew 7.7% in FY2025 to $12.0B, from $11.2B a year earlier.
Profit margin: The net margin was 12.1% in FY2025, down from 13.8% the year before.
Profitable: HLT earned $1.5B in FY2025.
Earnings reality check
Did HLT beat what analysts expected, and how did the stock react?
Earnings record: HLT beat the analyst estimate in 8 of the last 8 quarters.
Market reaction: The stock fell in the first session after 4 of those 8 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 27, 2026before open | $2.37 | $2.45 | +3.38% | -2.06% | +3.64% |
| Jul 28, 2026before open | $2.27 | $2.29 | +0.88% | -2.54% | -4.99% |
| Apr 28, 2026before open | $1.97 | $2.01 | +2.03% | -2.73% | -6.34% |
| Feb 11, 2026before open | $2.02 | $2.08 | +2.97% | +0.44% | -2.42% |
| Oct 22, 2025before open | $2.05 | $2.11 | +2.93% | +3.42% | -1.90% |
| Jul 23, 2025before open | $2.04 | $2.20 | +7.84% | -2.55% | -0.28% |
| Apr 29, 2025before open | $1.61 | $1.72 | +6.83% | +2.17% | +7.83% |
| Feb 6, 2025before open | $1.68 | $1.76 | +4.76% | +4.86% | +6.05% |
As of November 6, 2026, HLT has beaten the analyst EPS estimate in 8 of its last 8 reported quarters and fell in the first trading session after 4 of those beats; its latest report, on October 27, 2026, came in 3.38% above the estimate and the stock moved -2.06% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
HLT AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 67.8, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 67.8 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of HLT
The score, the reasoning behind it, and what could move the price next.
Hilton Worldwide Holdings Inc. (HLT) is in an upward trend. The stock trades at $370.45, which is 12.59% above its 50-day average of $329.03 and 14.81% above its 200-day average of $322.66. It sits near the top of its 52-week range: the price is 2.86% below the high of $381.34 and 40.35% above the low of $263.95. The 50-day average is 1.97% above the 200-day, which backs up the move instead of working against it.
The 14-day RSI of 67.8 is in the bullish zone, below the overbought line, and the MACD line is positive. The recent returns are all positive: the price rose 16.64% over the past three months, rose 16.94% over the past six months and rose 39.65% over the past year.
Analyst upgrade ›
Mizuho upgraded it to Outperform from Neutral on October 29, 2026.
Source: Analyst action, Mizuho, October 29, 2026Rating reaffirmed ›
Argus Research kept its Buy rating on October 30, 2026.
Source: Analyst action, Argus Research, October 30, 2026
Earnings beat, but the stock fell ›
The October 27, 2026 report beat the EPS estimate by 3.38%, and the share price fell 2.06% in the first session after it.
Source: Earnings report, October 27, 2026
- Two levels matter most. The 52-week high at $381.34 is the first one above the price, and the 20-day EMA at $353.30 is the first one below it.
- With the 14-day RSI at 67.8, momentum reads as bullish and the MACD line is positive. Readings above 70 or below 30 would signal stretched momentum.
- The share price fell 2.06% in the first session after the October 27, 2026 report. Across the last 8 reports, HLT beat estimates in 8 of 8.
The uptrend rests on HLT staying above its 50-day average at $329.03 and its 200-day average at $322.66; a close below the 50-day would be the first crack in it. On a pullback, the first level the price would meet is the 20-day EMA at $353.30.
The next level above the price is the 52-week high at $381.34. The RSI is in the bullish zone, which means momentum still supports the move.
Technical indicators
Momentum and trend for HLT, from its daily closes.
As of November 6, 2026, with HLT at $370.45, its 14-day RSI is 67.8 (showing bullish momentum without being overbought), its 50-day simple moving average is $329.03 and its 200-day is $322.66.
Calculated by CleaRank on daily closes as of November 6, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What HLT moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of November 6, 2026, HLT's 1-year correlation of daily returns is +0.56 with S&P 500 (SPY), +0.44 with Nasdaq 100 (QQQ), +0.11 with Bitcoin (BTC) and +0.04 with gold (XAU).
HLT price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
19 of 29 analysts rate it a buy or strong buy, 9 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $374.00 is 1.0% above the price.Larger share of buy ratings than three months ago ›
19 of 29 rate it a buy now, against 14 of 25 three months ago.
HLT Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 30, 2026 | Argus Research | Maintains | Buy |
| Oct 29, 2026 | Macquarie | Maintains | Neutral |
| Oct 29, 2026 | Mizuho | Upgrade | Outperform |
| Oct 28, 2026 | Morgan Stanley | Maintains | Overweight |
| Oct 28, 2026 | Barclays | Maintains | Overweight |
| Oct 28, 2026 | Wells Fargo | Maintains | Overweight |
As of November 6, 2026, 29 Wall Street analysts cover HLT: 19 rate it a buy or strong buy, 9 a hold and 1 a sell or strong sell. Their 12-month price targets range from $275.00 to $421.00. The median HLT price target is $374.00, 1.0% above the price of $370.45.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
HLT risk and volatility
How much it moves day to day, and how it stacks up against similar assets.
Risk profile
How much HLT tends to move, against the market and on its own.
HLT price history and drawdowns
HLT's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Typical daily move under 2% ›
A typical daily move is 1.68% (the standard deviation of the last 30 daily returns).Recovered from its worst fall ›
The worst fall was 44.0%, from February 2020 to March 2020, regained by February 2021.Most 1-year holds ended higher ›
80% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since December 2016 ›
$10,000 invested in December 2016 is now worth $74,462, against $39,188 in the S&P 500 (SPY).
HLT Drawdowns & Recovery
As of November 6, 2026, HLT's worst peak-to-trough fall over the last 10 years with dividends reinvested was -44.0% (February 2020 to March 2020); it regained that peak by February 2021, 11 months after the low, and 80% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into HLT in December 2016 is worth now, against the same amount in the S&P 500.
Against the market: HLT beat the S&P 500 over this period: $74,462 against $39,188.
A $10,000 investment in HLT in December 2016 would be worth about $74,462 today with dividends reinvested, compared with about $39,188 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to HLT, and which have not.
Strongest month, November: an average of +7.34%, up in 8 of 9 years.
Weakest month, March: an average of -4.43%, up in 4 of 10 years.
This month, November: has averaged +7.34%, up in 8 of 9 years. Past seasonality does not repeat on schedule.
Across 10 calendar years of history, HLT's strongest calendar month has been November (average +7.34%, up in 8 of 9 years) and its weakest March (average -4.43%, up in 4 of 10 years).
Average return for each calendar month across 10 calendar years of history, from weekly closing prices with dividends included.
HLT stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in HLT, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in HLT today could grow to about $14,985 by 2030 in the base case, with a 90th-percentile outcome near $31,390 and a 10th-percentile outcome around $7,153. The simulation models price only; at today's 0.16% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
HLT Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $555 for HLT by 2030 in the base case, from $370 today (1.5x over 4 years). The 10th-percentile path ends near $265. These are outcomes of a Monte Carlo simulation run on HLT's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $283 | $410 | $593 | |
| 2028 | $269 | $453 | $765 | |
| 2029 | $264 | $502 | $952 | |
| 2030 | $265 | $555 | $1,163 |
Method: a lognormal simulation of HLT's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
HLT insider trading
What the people running the company have bought and sold.
HLT insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought HLT shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of November 6, 2026, HLT insiders reported 4 open-market sales worth $41.9M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Charlene T Begley
Director
|
Grant | 6 | - |
| Sep 30, 2026 | Chris Carr
Director
|
Grant | 2 | - |
| Sep 30, 2026 | Jonathan D. Gray
Director
|
Grant | 4 | - |
| Sep 30, 2026 | Melanie L Healey
Director
|
Grant | 6 | - |
| Sep 30, 2026 | Raymond E Mabus Jr
Director
|
Grant | 5 | - |
| Sep 30, 2026 | Marissa A Mayer
Director
|
Grant | 0 | - |
| Sep 30, 2026 | Elizabeth A Smith
Director
|
Grant | 8 | - |
| Sep 30, 2026 | Douglas M Steenland
Director
|
Grant | 9 | - |
| Sep 14, 2026 | Laura Fuentes
Officer
|
Sell | 7.3K | $2.3M |
| Sep 14, 2026 | Chris Carr
Director
|
Sell | 439 | $136.2K |
| Sep 14, 2026 | Laura Fuentes
Officer
|
Option | 12.8K | $848.3K |
| Jun 30, 2026 | Charlene T Begley
Director
|
Grant | 5 | - |
| Jun 30, 2026 | Chris Carr
Director
|
Grant | 2 | - |
| Jun 30, 2026 | Jonathan D. Gray
Director
|
Grant | 4 | - |
| Jun 30, 2026 | Melanie L Healey
Director
|
Grant | 6 | - |
| Jun 30, 2026 | Raymond E Mabus Jr
Director
|
Grant | 5 | - |
| Jun 30, 2026 | Marissa A Mayer
Director
|
Grant | 0 | - |
| Jun 30, 2026 | Elizabeth A Smith
Director
|
Grant | 8 | - |
| Jun 30, 2026 | Douglas M Steenland
Director
|
Grant | 8 | - |
| May 14, 2026 | Charlene T Begley
Director
|
Grant | 742 | - |
| May 14, 2026 | Chris Carr
Director
|
Grant | 742 | - |
| May 14, 2026 | Jonathan D. Gray
Director
|
Grant | 742 | - |
| May 14, 2026 | Melanie L Healey
Director
|
Grant | 742 | - |
| May 14, 2026 | Raymond E Mabus Jr
Director
|
Grant | 742 | - |
| May 14, 2026 | Marissa A Mayer
Director
|
Grant | 742 | - |
| May 14, 2026 | Elizabeth A Smith
Director
|
Grant | 742 | - |
| May 14, 2026 | Douglas M Steenland
Director
|
Grant | 742 | - |
| May 1, 2026 | Jonathan D. Gray
Director
|
Grant | 104 | - |
| May 1, 2026 | Marissa A Mayer
Director
|
Grant | 115 | - |
| May 1, 2026 | Elizabeth A Smith
Director
|
Grant | 145 | - |
| Mar 31, 2026 | Charlene T Begley
Director
|
Grant | 6 | - |
| Mar 31, 2026 | Chris Carr
Director
|
Grant | 3 | - |
| Mar 31, 2026 | Jonathan D. Gray
Director
|
Grant | 4 | - |
| Mar 31, 2026 | Melanie L Healey
Director
|
Grant | 6 | - |
| Mar 31, 2026 | Raymond E Mabus Jr
Director
|
Grant | 6 | - |
| Mar 31, 2026 | Marissa A Mayer
Director
|
Grant | 0 | - |
| Mar 31, 2026 | Elizabeth A Smith
Director
|
Grant | 9 | - |
| Mar 31, 2026 | Douglas M Steenland
Director
|
Grant | 9 | - |
| Feb 25, 2026 | Christian H. Charnaux
Officer
|
Grant | 2.2K | - |
| Feb 25, 2026 | Laura Fuentes
Officer
|
Grant | 11.0K | - |
| Feb 25, 2026 | Kevin J Jacobs
Chief Financial Officer
|
Grant | 31.6K | - |
| Feb 25, 2026 | Caroline Krass
General Counsel
|
Grant | 2.2K | - |
| Feb 25, 2026 | Misha Moylan
Officer
|
Grant | 292 | - |
| Feb 25, 2026 | Christopher J Nassetta
Chief Executive Officer
|
Grant | 105.8K | - |
| Feb 25, 2026 | Christopher W Silcock
Officer
|
Grant | 17.6K | - |
| Feb 17, 2026 | Christopher J Nassetta
Chief Executive Officer
|
Sell | 114.3K | $36.3M |
| Feb 17, 2026 | Christopher J Nassetta
Chief Executive Officer
|
Option | 114.3K | $4.7M |
| Dec 29, 2025 | Charlene T Begley
Director
|
Grant | 6 | - |
| Dec 29, 2025 | Chris Carr
Director
|
Grant | 3 | - |
| Dec 29, 2025 | Jonathan D. Gray
Director
|
Grant | 4 | - |
| Dec 29, 2025 | Melanie L Healey
Director
|
Grant | 7 | - |
| Dec 29, 2025 | Raymond E Mabus Jr
Director
|
Grant | 6 | - |
| Dec 29, 2025 | Marissa A Mayer
Director
|
Grant | 0 | - |
| Dec 29, 2025 | Elizabeth A Smith
Director
|
Grant | 9 | - |
| Dec 29, 2025 | Douglas M Steenland
Director
|
Grant | 9 | - |
| Sep 30, 2025 | Charlene T Begley
Director
|
Grant | 7 | - |
| Sep 30, 2025 | Chris Carr
Director
|
Grant | 3 | - |
| Sep 30, 2025 | Jonathan D. Gray
Director
|
Grant | 4 | - |
| Sep 30, 2025 | Melanie L Healey
Director
|
Grant | 8 | - |
| Sep 30, 2025 | Raymond E Mabus Jr
Director
|
Grant | 7 | - |
| Sep 30, 2025 | Marissa A Mayer
Director
|
Grant | 0 | - |
| Sep 30, 2025 | Elizabeth A Smith
Director
|
Grant | 10 | - |
| Sep 30, 2025 | Douglas M Steenland
Director
|
Grant | 10 | - |
| Aug 21, 2025 | Christopher W Silcock
Officer
|
Sell | 11.9K | $3.2M |
| Aug 21, 2025 | Christopher W Silcock
Officer
|
Option | 11.9K | $493.0K |
| Aug 5, 2025 | Christian H. Charnaux
Officer
|
Grant | 12.2K | - |
| Jun 27, 2025 | Charlene T Begley
Director
|
Grant | 7 | - |
| Jun 27, 2025 | Chris Carr
Director
|
Grant | 3 | - |
| Jun 27, 2025 | Jonathan D. Gray
Director
|
Grant | 4 | - |
| Jun 27, 2025 | Melanie L Healey
Director
|
Grant | 7 | - |
| Jun 27, 2025 | Raymond E Mabus Jr
Director
|
Grant | 6 | - |
| Jun 27, 2025 | Marissa A Mayer
Director
|
Grant | 0 | - |
| Jun 27, 2025 | Elizabeth A Smith
Director
|
Grant | 10 | - |
| Jun 27, 2025 | Douglas M Steenland
Director
|
Grant | 10 | - |
| May 14, 2025 | Charlene T Begley
Director
|
Grant | 928 | - |
| May 14, 2025 | Chris Carr
Director
|
Grant | 928 | - |
| May 14, 2025 | Jonathan D. Gray
Director
|
Grant | 928 | - |
| May 14, 2025 | Melanie L Healey
Director
|
Grant | 928 | - |
| May 14, 2025 | Raymond E Mabus Jr
Director
|
Grant | 928 | - |
| May 14, 2025 | Marissa A Mayer
Director
|
Grant | 928 | - |
| May 14, 2025 | Elizabeth A Smith
Director
|
Grant | 928 | - |
| May 14, 2025 | Douglas M Steenland
Director
|
Grant | 928 | - |
Source: TwelveData, from SEC Form 4 filings
HLT stock forecast: questions people ask
Answered from the figures on this page, as of November 6, 2026.